Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
18,451,685
-
Share change
-
-628,640
-
Total reported value
-
$274,906,569
-
Put/Call ratio
-
64%
-
Price per share
-
$14.90
-
Number of holders
-
91
-
Value change
-
-$8,777,395
-
Number of buys
-
47
-
Number of sells
-
29
Institutional Holders of EIGER BIOPHARMACEUTICALS INC - COM (EIGR) as of Q4 2019
As of 31 Dec 2019,
EIGER BIOPHARMACEUTICALS INC - COM (EIGR) was held by
91 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,451,685 shares.
The largest 10 holders included
ADAGE CAPITAL PARTNERS GP, L.L.C., BlackRock Inc., 683 Capital Management, LLC, Broadfin Capital, LLC, VANGUARD GROUP INC, FARALLON CAPITAL MANAGEMENT LLC, MANGROVE PARTNERS, Cormorant Asset Management, LP, INTERWEST VENTURE MANAGEMENT CO, and EcoR1 Capital, LLC.
This page lists
91
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.